BENEFITS OF PHARMACOTHERAPEUTIC FOLLOW-UP FOR THE TREATMENT OF PATIENTS WITH DIABETES MELLITUS: A INTEGRATIVE REVIEW. RECIMA21 2021, 2 (9), e29726. https://doi.org/10.47820/recima21.v2i9.726.